| Primary |
| Electrolyte Substitution Therapy |
19.6% |
| Pain |
11.8% |
| Stupor |
11.8% |
| Arthritis |
9.8% |
| Product Used For Unknown Indication |
7.8% |
| Anaesthesia |
3.9% |
| Hypertension |
3.9% |
| Hypotension |
3.9% |
| Hypothyroidism |
3.9% |
| Procedural Pain |
3.9% |
| Restlessness |
3.9% |
| Appendicectomy |
2.0% |
| Constipation |
2.0% |
| Depression |
2.0% |
| Hyperglycaemia |
2.0% |
| Polyuria |
2.0% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.0% |
| Sepsis |
2.0% |
| Thrombosis Prophylaxis |
2.0% |
|
| Drug Effect Increased |
20.0% |
| Overdose |
20.0% |
| Respiratory Depression |
20.0% |
| Toxic Epidermal Necrolysis |
20.0% |
| Urine Output Decreased |
20.0% |
|
| Secondary |
| Product Used For Unknown Indication |
14.4% |
| Hypertension |
13.4% |
| Pain |
11.8% |
| Psoas Abscess |
11.3% |
| Supplementation Therapy |
8.6% |
| Thrombosis Prophylaxis |
4.4% |
| Hyperglycaemia |
4.3% |
| Restlessness |
4.0% |
| Electrolyte Substitution Therapy |
3.7% |
| Prophylaxis |
3.2% |
| Stupor |
3.0% |
| Polyuria |
2.9% |
| Secretion Discharge |
2.5% |
| Hypothyroidism |
2.1% |
| Intervertebral Disc Protrusion |
2.0% |
| Pyrexia |
2.0% |
| Psoriatic Arthropathy |
1.7% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.6% |
| Constipation |
1.5% |
| Sepsis |
1.5% |
|
| Stevens-johnson Syndrome |
41.3% |
| Toxic Epidermal Necrolysis |
10.9% |
| Drug Effect Increased |
6.5% |
| Feeding Disorder Neonatal |
4.3% |
| Left Ventricular Failure |
4.3% |
| Pain |
4.3% |
| Psoriatic Arthropathy |
4.3% |
| Respiratory Failure |
4.3% |
| Ileus |
2.2% |
| Neonatal Respiratory Distress Syndrome |
2.2% |
| Premature Baby |
2.2% |
| Premature Labour |
2.2% |
| Premature Rupture Of Membranes |
2.2% |
| Restlessness |
2.2% |
| Stomatitis |
2.2% |
| Thermal Burn |
2.2% |
| Vascular Graft |
2.2% |
|
| Concomitant |
| Prophylaxis |
11.3% |
| Hypertension |
10.4% |
| Infection |
10.1% |
| Pain |
9.1% |
| Constipation |
8.0% |
| Sepsis |
5.7% |
| Thrombosis Prophylaxis |
4.7% |
| Sedation |
4.5% |
| Anaesthesia |
4.1% |
| Product Used For Unknown Indication |
4.1% |
| Nausea |
3.3% |
| Fungal Infection |
3.1% |
| Bacterial Infection |
3.1% |
| Infection Prophylaxis |
3.1% |
| Lung Infection |
3.1% |
| Supplementation Therapy |
2.9% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.8% |
| Pain Prophylaxis |
2.4% |
| Analgesic Therapy |
2.1% |
| Drug Use For Unknown Indication |
2.1% |
|
| Ureterostomy Site Discomfort |
15.7% |
| Toxic Epidermal Necrolysis |
11.8% |
| Agranulocytosis |
7.9% |
| Pulmonary Embolism |
7.1% |
| Renal Failure |
4.7% |
| Tachyarrhythmia |
4.7% |
| Thrombocytopenia |
4.7% |
| Death |
3.9% |
| Stevens-johnson Syndrome |
3.9% |
| Tachycardia |
3.9% |
| Vanishing Bile Duct Syndrome |
3.9% |
| Vomiting |
3.9% |
| Leukopenia |
3.1% |
| Renal Failure Acute |
3.1% |
| Toxicity To Various Agents |
3.1% |
| Tumour Haemorrhage |
3.1% |
| Wound Infection |
3.1% |
| Wound Secretion |
3.1% |
| Cholestasis |
2.4% |
| Pleural Effusion |
2.4% |
|
